Roberto Mallone
Roberto Mallone is an expert in Endocrinology at Hôpital Cochin (France). As of May 2026, ScienceLeadR ranks Roberto Mallone in the top 1% of experts worldwide for Diabetes Mellitus, Glucose Metabolism Disorders and Autoimmune Diseases. Roberto Mallone has authored 154 publications, the most recent in 2026, and is an investigator in 10 clinical trials, 3 of them ongoing. SLR score: 870 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Immunology - Neurology - Hematology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1998 - 2026
Number : 154
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Persistence of proinsulin-only secretion in people with long-duration diabetes and minimal residual insulin secretion. PMID 42174769 — diabetes mellitus, cells, proinsulin, insulin, insulin secretion, meals | Diabet Med | 2026 | 0 |
| Real-time in vivo analysis of murine β cells reveals autophagic flux defects before onset of autoimmune diabetes. PMID 42160447 — diabetes mellitus, cells, diabetes mellitus, type 1 | Sci Transl Med | 2026 | 0 |
| Type 1 diabetes: to screen or not to screen? PMID 41690404 — diabetes mellitus, diabetes mellitus, type 1 | Ann Endocrinol (Paris) | 2026 | 0 |
| Type 1 diabetes screening: building a clinician-patient partnership for early care of chronic beta cell failure. PMID 41572011 — diabetes mellitus, cells, diabetes mellitus, type 1 | Diabetologia | 2026 | 0 |
| Killing of Human β-Cells by CD8+ T Cells Triggers Inflammatory Paracrine Signaling and Neighboring β-Cell Dysfunction. PMID 41218919 — diabetes mellitus, cells, paracrine communication, diabetes mellitus, type 1 | Diabetes | 2025 | 0 |
Clinical Studies 10
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At Risk Children and Adults NCT07222137 — diabetes mellitus, aged, diabetes mellitus, type 1, child | Phase 3 | Recruiting | 2026 |
| INNODIA Family Friends Early Stage T1D Detection Protocol NCT07118098 — diabetes mellitus, cells, autoantibodies, blood glucose, insulin, blood, glucose intolerance, signs and symptoms, diabetes mellitus, type 1, child | N/A | Recruiting | 2025 |
| BeAT1D Benign Autoimmunity and Type 1 Diabetes NCT05139784 — diabetes mellitus, cells, blood, lymph nodes, lymphocytes, lymph node excision, biomarkers, lymph, autoimmune diseases, diabetes mellitus, type 1, autoimmunity | N/A | Recruiting | 2022 |
LeadR Networks
Main global connection map